Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Medipharm Labs Sells Off Australian Assets

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Jul 11, 2022 8:24am

137 Views

Post# 34814611

RE:Medipharm Labs Sells Off Australian Assets

Never made sense to have 2 plants when 1 could service the entire world. Utilizing more of the plant capacity in Canada will bring down cost of sales.

AwareInvestor wrote:
MediPharm Labs appears to be slowly pulling back on its international endeavours. The firm this morning announced the sale of its Australia operations, which will be sold to a local operator.

https://thedeepdive.ca/medipharm-labs-sells-off-australian-assets/